Seroprevalence, Risk Factors and Immunological Response against Hepatitis B Virus Among Students of Usmanu Danfodiyo University Sokoto, Nigeria
DOI:
https://doi.org/10.47430/ujmr.2493.063Keywords:
HBsAg, Hepatitis B Virus, Risk Factors, Seroprevalence, Usmanu Danfodiyo University SokotoAbstract
Study’s Excerpt
- The seroprevalence of Hepatitis B Virus (HBV) among university students was investigated.
- Both serological markers of HBV and immune response were assessed.
- The results revealed significant associations between infection and high-risk behaviors.
Full Abstract
Hepatitis B Virus is of major public health interest as it accounts for significant mortality globally. The study aimed to determine the seroprevalence of HBV infection, the possible potential risk factors, and the immunological response among students of Usmanu Danfodiyo University, Sokoto, from December 2022 to April 2023. Structured questionnaires were used to collect sociodemographic information as well as possible risk factors related to the infection. Out of 139 study participants (10 females and 129 males screened randomly for HBsAg using a rapid HBsAg test kit, 17 (12.2%) were seropositive, and 122 (87.8%) were seronegative. The sera of the positive participants were further screened for HBeAg, anti-(HBs, HBe, and HBc) using one-step cassette diagnostic kits. Of the 17 positive samples screened, none were reactive for anti-HBs antibodies and HBeAg.; while 15 were positive anti-HBc and anti-HBe, indicating a response to natural infection. Sexual activity, unprotected sexual practices, use of already used sharp objects, and awareness of HBV infection were significantly associated (P<0.05) with the viral infection. The study indicates high endemicity in the study area. It is recommended that Nigerian Universities mandate the Hepatitis B virus vaccine for newly intake students. More awareness should be created about the dangers of unprotected sexual practice use or sharing of used sharp objects, among other possible factors.
Downloads
References
Adenlewo, O. J., Adeosun, P. O., & Fatusi, O. A. (2017). Medical and dental students’ attitude and practice of prevention strategies against hepatitis B virus infection in a Nigerian university. The Pan African Medical Journal, 28, 33. https://doi.org/10.11604/pamj.2017.28.33.11662
Ansumana, R., Dariano, D. F., Jacobsen, K. H., Łęski, T. A., Lamin, J. M., Lahai, J., Bangura, U., Bockarie, A. S., Taitt, C. R., Yasuda, C. Y., Bockarie, M. J., & Stenger, D. A. (2018). Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012–2013. BMC Research Notes, 11, 113. https://doi.org/10.1186/s13104-018-3218-8
Bottéro, J., Boyd, A., Gozlan, J., Lemoine, M., Carrat, F., Collignon, A., Boo, N., Dhotte, P., Varsat, B., Müller, G., Cha, O., Picard, O., Nau, J., Campa, P., Silbermann, B., Bary, M., Girard, P., & Lacombe, K. (2013). Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France. Journal of Hepatology, 58(3), 473–478. https://doi.org/10.1016/j.jhep.2012.11.016
Campos-Valdez, M., Monroy-Ramírez, H. C., Armendáriz‐Borunda, J., & Sánchez-Orozco, L. V. (2021). Molecular mechanisms during Hepatitis B infection and the effects of the virus variability. Viruses, 13(6), 1167. https://doi.org/10.3390/v13061167
Dagnew, M., Million, Y., Gizachew, M., Eshetie, S., Yitayew, G., Asrade, L., Adefris, M., Moges, F., & Tiruneh, M. (2020). Hepatitis B and C viruses’ infection and associated factors among pregnant women attending antenatal care in hospitals in the Amhara National Regional State, Ethiopia. International Journal of Microbiology, 2020, 848561, 1–11. https://doi.org/10.1155/2020/8848561
Deng, X., Guo, X., Gu, H., Wang, D., Laperche, S., Allain, J., Zang, L., & Candotti, D. (2022). Anti‐HBc‐nonreactive occult hepatitis B infections with HBV genotypes B and C in vaccinated immunocompetent adults. Journal of Viral Hepatitis, 29(11), 958-967. https://doi.org/10.1111/jvh.13733
Isa, I., Aminu, M., Abdullahi, S. A., Sani, M. A. M., & Esona, M. D. (2015). Seroprevalence of hepatitis B virus in a tertiary institution in North Western Nigeria. African Journal of Microbiology Research, 9(3), 171–179. https://doi.org/10.5897/ajmr2014.7068
Isa, I., Aminu, M., Abdullahi, S. A., Sani, M. a. M., Usman, M., Esona, M. D., & Ella, E. E. (2017). Seroprevalence of Hepatitis B Virus and Human Immunodeficiency Virus infection among students in Ahmadu Bello University, Zaria, Nigeria. Archives of Medical and Biomedical Research, 3(2), 77. https://doi.org/10.4314/ambr.v3i2.4
Ndako. A. J., Obinna. O. N., Georgebest. O. N., Echeonwu. S. A., Junaid. O. A., & Tiri. J. A. (2011). Studies on prevalence and risk factors for Hepatitis B Surface Antigen among secondary school students in North-central Nigeria. Sierra Leone Journal of Biomedical Research, 3(3), 163-168. http://dx.doi.org/10.4314/sljbr.v3i3.
Ndongo, C. B., Eteki, L., Siedner, M. J., Mbaye, R., Chen, J., Ntonè, R., Donfack, O. S., Bongwong, B., Evoue, R. E., Zeh, F., Njouom, R., Nguefack‐Tsague, G., Mballa, G. a. E., Sida, M. B., & Boum, Y. (2018). Prevalence and vaccination coverage of Hepatitis B among healthcare workers in Cameroon: A national seroprevalence survey. Journal of Viral Hepatitis, 25(12), 1582–1587. https://doi.org/10.1111/jvh.12974
Okeke, E., Ladep, N. G., Agaba, E. I., & Malu, A. O. (2008). Hepatitis B vaccination status and needle stick injuries among medical students in a Nigerian university. Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria, 17(3), 330-332. https://doi.org/10.4314/njm.v17i3.37404
Okwesili, A., Onuigwe, F. U., Ibrahim, K. G., Buhari, H. A., Ibrahim, A. D., Jafaru, H., Erhabor, O., Zama, I., Ahmed, M., Mainasara, M. Y., Adias, T. C., Yeldu, M. H., Uko, E. K., & Udoma, F. (2015). Prevalence of Hepatitis B surface antigen among biomedical students of African descent in Usmanu Danfodiyo University, Sokoto, Nigeria. Human Antibodies, 23(3–4), 57–62. https://doi.org/10.3233/hab-150282
Otegbayo, J. A., Taiwo, B., Akingbola, T. S., Odaibo, G. N., Adedapo, K. S., Penugonda, S., Adewole, I. F., Olaleye, D. O., Murphy, R., & Kanki, P. J. (2008). Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Annals of Hepatology, 7(2), 152–156. https://doi.org/10.1016/s1665-2681(19)31872-1
Otori, M. O., Aminu, M., Mukhtar, H. M., & Okojokwu, O. J. (2013). Predominant blood group antigen and risk factors associated with HIV infection among HIV positive patients in Zaria, Kaduna state, Nigeria. International Journal of Pharmaceutical, Chemical and Biological Sciences, 3(4), 1052-1060.
Otori. M. O., Aminu, M., Muktar, H. M., Ellah, E. E., Shaibu, A. M. (2014) Seroprevalence of human immunodeficiency virus and hepatitis B virus among blood donors in selected hospitals in Zaria, Kaduna state, Nigeria. Novus International Journal of Biotechnology and Bioscience, 3(1), 1-9.
Park, J. W., Kwak, K., Kim, S. E., Jang, M. K., Kim, D. J., Lee, M. S., Kim, H. S., & Park, C. K. (2015). Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients. World Journal of Gastroenterology, 21(13), 3953. https://doi.org/10.3748/wjg.v21.i13.3953
Rabaan, A. A., Bello, K. E., Irekeola, A. A., Kaabi, N. A., Halwani, M. A., Yousuf, A., Alshengeti, A., Alfaraj, A. H., Khamis, F., Al-Subaie, M. F., AlShehail, B. M., Almuthree, S. A., Ibraheem, N. M. M., Khalifa, M. H., Alfaresi, M., Fares, M. a. A., Garout, M., Alsayyah, A., Alshehri, A. A., Alqahtani, A. S., & Alissa, M. (2023). Prevalence of hepatocellular carcinoma in Hepatitis B population within Southeast Asia: A systematic review and meta-analysis of 39,050 participants. Pathogens, 12(10), 1220. https://doi.org/10.3390/pathogens12101220
Tesfa, T., Hawulte, B., Tolera, A., & Abate, D. (2021b). Hepatitis B virus infection and associated risk factors among medical students in eastern Ethiopia. PLOS ONE, 16(2), e0247267. https://doi.org/10.1371/journal.pone.0247267
Tula, M. Y., & Iyoha, O. (2015). A cross-sectional study on the seroprevalence of HBsAg among apparently healthy students of a tertiary institution in North-eastern Nigeria. International Journal of Tropical Disease & Health, 7(3), 102-108.
World Health Organisation (2023). In Nigeria, boosting viral hepatitis awareness and treatment. WHO | Regional Office for Africa. https://www.afro.who.int/countries/nigeria/news/nigeria-boosting-viral-hepatitis-awareness-and-treatment-0
World Health Organization (2016). Prevalence of hepatitis B virus infection in the world by country. http://www.who.int/csr/disease/hepati tis/en/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Abusufyan Saifullahi, Kabir Mohammed, Kaab Salisu Sodangi, Badaru Abdulkarim
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
